Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Atenolol measurement |
Component |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol poisoning |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Accidental atenolol poisoning |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Intentional atenolol poisoning |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
intoxication par l'aténolol d'intention indéterminée |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol adverse reaction |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol overdose (disorder) |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Accidental atenolol overdose |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Intentional atenolol overdose |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
surdose d'aténolol d'intention indéterminée |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 25mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
aténolol 500 microgrammes/mL, ampoule de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Co-tenidone 100mg/25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 50mg / nifedipine 20mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol+calcium channel blocker |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol+diuretic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Co-tenidone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Product containing atenolol and bendroflumethiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing amiloride and atenolol and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Product containing atenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing atenolol and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing atenolol and chlortalidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Accidental atenolol poisoning |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Intentional atenolol poisoning |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Allergy to atenolol (finding) |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
|
Atenolol adverse reaction (disorder) |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol sensitivity |
Causative agent (attribute) |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing atenolol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Allergy to atenolol (finding) |
Causative agent (attribute) |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Amiloride- and atenolol- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol- and bendroflumethiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol- and chlortalidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and chlortalidone 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 25 mg and bendroflumethiazide 1.25 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and chlortalidone 12.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 100 mg and chlortalidone 25 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely atenolol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atenolol 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atenolol 5 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atenolol 5 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing atenolol and nifedipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only amiloride and atenolol and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only atenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing only atenolol and nifedipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only atenolol and bendroflumethiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing only atenolol and chlortalidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only amiloride and atenolol and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Product containing only atenolol and bendroflumethiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol and chlortalidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol and nifedipine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only atenolol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 500 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 500 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
1 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol 50 mg and nifedipine 20 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Amlodipine- and atenolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing amlodipine and atenolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only amlodipine and atenolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only amlodipine and atenolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atenolol 50 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol and levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Atenolol- and levamlodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |
Product containing only atenolol and levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atenolol (substance) |
Inferred relationship |
Some |
2 |